Uterine Fibroid Embolization Device Market

The global Uterine Fibroid Embolization Device market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Gelatin Sponge segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Uterine Fibroid Embolization Device include Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc., Aetna Better Health of Pennsylvania, Ethicon US, LLC, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Uterine Fibroid Embolization Device manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
Uterine Fibroid Embolization Device Market aims to provide a comprehensive presentation of the global market for Uterine Fibroid Embolization Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Fibroid Embolization Device. Uterine Fibroid Embolization Device Market contains market size and forecasts of Uterine Fibroid Embolization Device in global, including the following market information:
Global Uterine Fibroid Embolization Device market revenue, 2020-2025, 2026-2032, ($ millions)
Global Uterine Fibroid Embolization Device market sales, 2020-2025, 2026-2032, (K Units)
Global top five Uterine Fibroid Embolization Device companies in 2024 (%)
Total Market by Segment:
Global Uterine Fibroid Embolization Device market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Uterine Fibroid Embolization Device market segment percentages, by Type, 2024 (%)
Gelatin Sponge
Polyvinyl Alcohol ( PVA ) Particles
Trisacryl Gelatin Microspheres ( TAGM )
Polymethyl Methacrylate ( PMMA ) Microspheres
Global Uterine Fibroid Embolization Device market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Uterine Fibroid Embolization Device market segment percentages, by Application, 2024 (%)
Hospitals
Clinics
Global Uterine Fibroid Embolization Device market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Uterine Fibroid Embolization Device market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Uterine Fibroid Embolization Device revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Uterine Fibroid Embolization Device revenues share in global market, 2024 (%)
Key companies Uterine Fibroid Embolization Device sales in global market, 2020-2025 (estimated), (K Units)
Key companies Uterine Fibroid Embolization Device sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
Merit Medical Systems
BioSpace
Hologic, Inc.
Cook Medical
Ferring B.V.
Smith+Nephew
CooperSurgical, Inc.
Aetna Better Health of Pennsylvania
Ethicon US, LLC
Olympus America
Stryker
Astellas Pharma
Nippon Kayaku
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Uterine Fibroid Embolization Device, market overview.
Chapter 2: Global Uterine Fibroid Embolization Device market size in revenue and volume.
Chapter 3: Detailed analysis of Uterine Fibroid Embolization Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Uterine Fibroid Embolization Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Uterine Fibroid Embolization Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.